• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外鉴定血管生成拟态的结构和功能。

Structural and functional identification of vasculogenic mimicry in vitro.

机构信息

Department of Physiology, Faculty of Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.

Division of Obstetrics & Gynecology, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

出版信息

Sci Rep. 2017 Aug 1;7(1):6985. doi: 10.1038/s41598-017-07622-w.

DOI:10.1038/s41598-017-07622-w
PMID:28765613
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5539303/
Abstract

Vasculogenic mimicry (VM) describes a process by which cancer cells establish an alternative perfusion pathway in an endothelial cell-free manner. Despite its strong correlation with reduced patient survival, controversy still surrounds the existence of an in vitro model of VM. Furthermore, many studies that claim to demonstrate VM fail to provide solid evidence of true hollow channels, raising concerns as to whether actual VM is actually being examined. Herein, we provide a standardized in vitro assay that recreates the formation of functional hollow channels using ovarian cancer cell lines, cancer spheres and primary cultures derived from ovarian cancer ascites. X-ray microtomography 3D-reconstruction, fluorescence confocal microscopy and dye microinjection conclusively confirm the existence of functional glycoprotein-rich lined tubular structures in vitro and demonstrate that many of structures reported in the literature may not represent VM. This assay may be useful to design and test future VM-blocking anticancer therapies.

摘要

血管生成拟态 (VM) 描述了癌细胞在没有内皮细胞的情况下建立替代灌注途径的过程。尽管它与患者生存时间缩短密切相关,但关于 VM 的体外模型是否存在仍存在争议。此外,许多声称能够证明 VM 的研究未能提供真正的空心通道的可靠证据,这引发了人们对是否真正在检查实际 VM 的质疑。在此,我们提供了一种标准化的体外检测方法,该方法使用卵巢癌细胞系、肿瘤球体和源自卵巢癌腹水的原代培养物来重现功能性空心通道的形成。X 射线微断层扫描 3D 重建、荧光共聚焦显微镜和染料微注射明确证实了体外存在功能性富含糖蛋白的 lined 管状结构,并表明文献中报道的许多结构可能不代表 VM。该检测方法可能有助于设计和测试未来的 VM 阻断抗癌治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcab/5539303/0bcb3a4463e0/41598_2017_7622_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcab/5539303/b3fd03b70c6f/41598_2017_7622_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcab/5539303/cd74bbf6b567/41598_2017_7622_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcab/5539303/975b407a9422/41598_2017_7622_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcab/5539303/7aa632d0ce55/41598_2017_7622_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcab/5539303/428dccfff7d1/41598_2017_7622_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcab/5539303/0bcb3a4463e0/41598_2017_7622_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcab/5539303/b3fd03b70c6f/41598_2017_7622_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcab/5539303/cd74bbf6b567/41598_2017_7622_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcab/5539303/975b407a9422/41598_2017_7622_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcab/5539303/7aa632d0ce55/41598_2017_7622_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcab/5539303/428dccfff7d1/41598_2017_7622_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bcab/5539303/0bcb3a4463e0/41598_2017_7622_Fig6_HTML.jpg

相似文献

1
Structural and functional identification of vasculogenic mimicry in vitro.体外鉴定血管生成拟态的结构和功能。
Sci Rep. 2017 Aug 1;7(1):6985. doi: 10.1038/s41598-017-07622-w.
2
cRGD inhibits vasculogenic mimicry formation by down-regulating uPA expression and reducing EMT in ovarian cancer.cRGD通过下调uPA表达并减少卵巢癌中的上皮-间质转化来抑制血管生成拟态的形成。
Oncotarget. 2016 Apr 26;7(17):24050-62. doi: 10.18632/oncotarget.8079.
3
Role of X‑linked inhibitor of apoptosis‑associated factor‑1 in vasculogenic mimicry in ovarian cancer.X连锁凋亡抑制相关因子-1在卵巢癌血管生成拟态中的作用
Mol Med Rep. 2017 Jul;16(1):325-330. doi: 10.3892/mmr.2017.6597. Epub 2017 May 17.
4
Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo.卵巢癌细胞SKOV3ip的可塑性及体内血管生成拟态
Int J Gynecol Cancer. 2008 May-Jun;18(3):476-86. doi: 10.1111/j.1525-1438.2007.01034.x. Epub 2007 Jul 21.
5
[Correlation of vasculogenic mimicry with clinicopathologic features and prognosis of ovarian carcinoma].[血管生成拟态与卵巢癌临床病理特征及预后的相关性]
Zhonghua Bing Li Xue Za Zhi. 2009 Sep;38(9):585-9.
6
Fact or Fiction, It Is Time for a Verdict on Vasculogenic Mimicry?血管生成拟态:是事实还是虚构?现在该做出判定了
Front Oncol. 2019 Aug 2;9:680. doi: 10.3389/fonc.2019.00680. eCollection 2019.
7
Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas.血管生成拟态与间皮肉瘤和肺泡横纹肌肉瘤患者的不良生存相关。
Int J Oncol. 2004 Dec;25(6):1609-14.
8
The role of miR-200a in vasculogenic mimicry and its clinical significance in ovarian cancer.miR-200a 在血管生成拟态中的作用及其在卵巢癌中的临床意义。
Gynecol Oncol. 2014 Mar;132(3):730-8. doi: 10.1016/j.ygyno.2014.01.047. Epub 2014 Feb 4.
9
Confocal Laser Microscopy for VM Analysis with DAPI and Phalloidin Staining.共聚焦激光显微镜用于 DAPI 和鬼笔环肽染色的 VM 分析。
Methods Mol Biol. 2022;2514:153-161. doi: 10.1007/978-1-0716-2403-6_15.
10
Role of hCG in vasculogenic mimicry in OVCAR-3 ovarian cancer cell line.hCG 在 OVCAR-3 卵巢癌细胞系血管生成拟态中的作用。
Int J Gynecol Cancer. 2011 Nov;21(8):1366-74. doi: 10.1097/IGC.0b013e31822c7529.

引用本文的文献

1
, but Not Rutin, Inhibits Survival, Migration, Invasion, and Vasculogenic Mimicry of Glioblastoma Cells.但芦丁不能抑制脑胶质瘤细胞的存活、迁移、侵袭和血管生成拟态。
Int J Mol Sci. 2024 Nov 2;25(21):11789. doi: 10.3390/ijms252111789.
2
Prognostic Influence of Galectin-1 in Gastric Adenocarcinoma.半乳糖凝集素-1在胃腺癌中的预后影响
Biomedicines. 2024 Jul 7;12(7):1508. doi: 10.3390/biomedicines12071508.
3
The in vitro dynamics of pseudo-vascular network formation.体外伪血管网络形成的动力学。

本文引用的文献

1
Visualization and Pathological Characteristics of Hepatic Alveolar Echinococcosis with Synchrotron-based X-ray Phase Sensitive Micro-tomography.基于同步辐射 X 射线相衬显微断层成像的肝泡型包虫病可视化及病理学特征
Sci Rep. 2016 Nov 29;6:38085. doi: 10.1038/srep38085.
2
Hypoxia-induced vasculogenic mimicry formation in human colorectal cancer cells: Involvement of HIF-1a, Claudin-4, and E-cadherin and Vimentin.缺氧诱导的人结直肠癌细胞血管生成拟态形成:涉及 HIF-1a、Claudin-4、E-钙黏蛋白和波形蛋白。
Sci Rep. 2016 Nov 21;6:37534. doi: 10.1038/srep37534.
3
Macrophages form functional vascular mimicry channels in vivo.
Br J Cancer. 2024 Aug;131(3):457-467. doi: 10.1038/s41416-024-02722-7. Epub 2024 Jun 20.
4
Intracellular pH dynamics respond to microenvironment stiffening and mediate vasculogenic mimicry through β-catenin.细胞内pH动态变化对微环境硬度增加做出反应,并通过β-连环蛋白介导血管生成拟态。
bioRxiv. 2024 Jun 4:2024.06.04.597454. doi: 10.1101/2024.06.04.597454.
5
Doxazosin inhibits vasculogenic mimicry in human non‑small cell lung cancer through inhibition of the VEGF‑A/VE‑cadherin/mTOR/MMP pathway.多沙唑嗪通过抑制VEGF‑A/VE‑钙黏蛋白/mTOR/MMP途径抑制人非小细胞肺癌中的血管生成拟态。
Oncol Lett. 2024 Feb 22;27(4):170. doi: 10.3892/ol.2024.14303. eCollection 2024 Apr.
6
Cancer Stem Cell and Aggressiveness Traits Are Promoted by Stable Endothelin-Converting Enzyme-1c in Glioblastoma Cells.癌症干细胞和侵袭性特征是由胶质母细胞瘤细胞中稳定的内皮素转换酶-1c 促进的。
Cells. 2023 Feb 3;12(3):506. doi: 10.3390/cells12030506.
7
Resveratrol suppresses serum-induced vasculogenic mimicry through impairing the EphA2/twist-VE-cadherin/AKT pathway in human prostate cancer PC-3 cells.白藜芦醇通过抑制 EphA2/ twist-VE 钙黏蛋白/AKT 通路抑制血清诱导的人前列腺癌 PC-3 细胞血管拟态形成。
Sci Rep. 2022 Nov 22;12(1):20125. doi: 10.1038/s41598-022-24414-z.
8
Crosstalk between tumor acidosis, p53 and extracellular matrix regulates pancreatic cancer aggressiveness.肿瘤酸中毒、p53 与细胞外基质之间的串扰调控胰腺癌侵袭性。
Int J Cancer. 2023 Mar 15;152(6):1210-1225. doi: 10.1002/ijc.34367. Epub 2022 Dec 1.
9
Cancer Three-Dimensional Spheroids Mimic In Vivo Tumor Features, Displaying "Inner" Extracellular Vesicles and Vasculogenic Mimicry.癌症三维球体模拟体内肿瘤特征,显示“内部”细胞外囊泡和血管生成拟态。
Int J Mol Sci. 2022 Oct 4;23(19):11782. doi: 10.3390/ijms231911782.
10
FOXC2 Promotes Vasculogenic Mimicry in Ovarian Cancer.FOXC2促进卵巢癌中的血管生成拟态。
Cancers (Basel). 2022 Oct 4;14(19):4851. doi: 10.3390/cancers14194851.
巨噬细胞在体内形成功能性血管拟态通道。
Sci Rep. 2016 Nov 11;6:36659. doi: 10.1038/srep36659.
4
Escaping Antiangiogenic Therapy: Strategies Employed by Cancer Cells.逃避抗血管生成治疗:癌细胞采用的策略
Int J Mol Sci. 2016 Sep 6;17(9):1489. doi: 10.3390/ijms17091489.
5
Micro-CT Imaging Reveals Mekk3 Heterozygosity Prevents Cerebral Cavernous Malformations in Ccm2-Deficient Mice.微计算机断层扫描成像显示,Mekk3基因杂合性可预防Ccm2基因缺陷小鼠的脑海绵状血管畸形。
PLoS One. 2016 Aug 11;11(8):e0160833. doi: 10.1371/journal.pone.0160833. eCollection 2016.
6
Association of Vasculogenic Mimicry Formation and CD133 Expression with Poor Prognosis in Ovarian Cancer.血管生成拟态形成及CD133表达与卵巢癌预后不良的相关性
Gynecol Obstet Invest. 2016;81(6):529-536. doi: 10.1159/000445747. Epub 2016 Apr 29.
7
CD133+ cancer stem-like cells promote migration and invasion of salivary adenoid cystic carcinoma by inducing vasculogenic mimicry formation.CD133+癌干细胞样细胞通过诱导血管生成拟态形成促进涎腺腺样囊性癌的迁移和侵袭。
Oncotarget. 2016 May 17;7(20):29051-62. doi: 10.18632/oncotarget.8665.
8
Tumor vasculogenic mimicry predicts poor prognosis in cancer patients: a meta-analysis.肿瘤血管生成拟态预测癌症患者预后不良:一项荟萃分析。
Angiogenesis. 2016 Apr;19(2):191-200. doi: 10.1007/s10456-016-9500-2. Epub 2016 Feb 22.
9
Evading anti-angiogenic therapy: resistance to anti-angiogenic therapy in solid tumors.逃避抗血管生成治疗:实体瘤对抗血管生成治疗的耐药性。
Am J Transl Res. 2015 Oct 15;7(10):1675-98. eCollection 2015.
10
Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancer.功能性长春新碱加达沙替尼脂质体在三阴性乳腺癌中对血管生成拟态通道的消除作用
Oncotarget. 2015 Nov 3;6(34):36625-42. doi: 10.18632/oncotarget.5382.